ESSENLIV Trademark

Trademark Overview

On Thursday, February 16, 2023, a trademark application was filed for ESSENLIV with the United States Patent and Trademark Office. The USPTO has given the ESSENLIV trademark a serial number of 97797840. The federal status of this trademark filing is FOURTH EXTENSION - GRANTED as of Tuesday, July 8, 2025. This trademark is owned by A. Nattermann & Cie. GmbH. The ESSENLIV trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical products for the treatment of liver diseases
essenliv

General Information

Serial Number97797840
Word MarkESSENLIV
Filing DateThursday, February 16, 2023
Status733 - FOURTH EXTENSION - GRANTED
Status DateTuesday, July 8, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 25, 2023

Trademark Statements

Goods and ServicesPharmaceutical products for the treatment of liver diseases

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, March 7, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameA. Nattermann & Cie. GmbH
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressFrankfurt am Main 65926
DE
Party NameA. Nattermann & Cie. GmbH
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressFrankfurt am Main 65926
DE

Trademark Events

Event DateEvent Description
Tuesday, June 13, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, February 20, 2023NEW APPLICATION ENTERED
Tuesday, March 7, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, June 6, 2023ASSIGNED TO EXAMINER
Tuesday, June 13, 2023NON-FINAL ACTION WRITTEN
Tuesday, June 13, 2023NON-FINAL ACTION E-MAILED
Wednesday, June 14, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, June 14, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, June 15, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, June 16, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, July 5, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, July 25, 2023PUBLISHED FOR OPPOSITION
Tuesday, July 25, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 19, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, February 27, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, February 27, 2024SOU EXTENSION 1 FILED
Tuesday, February 27, 2024SOU EXTENSION 1 GRANTED
Wednesday, February 28, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, August 21, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, August 21, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, August 21, 2024SOU EXTENSION 2 FILED
Wednesday, August 21, 2024SOU EXTENSION 2 GRANTED
Wednesday, February 19, 2025TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Monday, February 24, 2025SOU TEAS EXTENSION RECEIVED
Monday, February 24, 2025SOU EXTENSION 3 FILED
Wednesday, February 19, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, February 19, 2025TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
Wednesday, February 19, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, February 19, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, February 24, 2025SOU EXTENSION 3 GRANTED
Tuesday, July 8, 2025SOU TEAS EXTENSION RECEIVED
Wednesday, July 9, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, July 8, 2025SOU EXTENSION 4 GRANTED
Monday, February 24, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, July 8, 2025SOU EXTENSION 4 FILED

Related Keywords

essenliv diseases liver treatment products pharmaceutical